ACR/ARP members can also schedule a time to meet directly with the ACR’s advocacy team to discuss issues and challenges you are facing.
Related Articles
FTC Bans Noncompete Agreements: What Rheumatologists Need to Know
The ACR applauds the FTC’s recent ban on most noncompete agreements. The ruling is a step in the right direction toward a more competitive market for healthcare workers and their services.
Status Check: Non-Compete Agreements in Healthcare
The FTC issued a Final Rule that banned non-compete agreements, but the rule was recently halted by a nationwide injunction from a federal court in Texas.
Federal Regulatory Actions Against Healthcare Consolidation
In recent months, the U.S. Department of Justice and Federal Trade Commission have started to take action to rein in antitrust behavior, including banning noncompete agreements in the for-profit sector and establishing a taskforce on healthcare monopolies.
Florida Law Puts Drug Pricing by Pharmacy Benefit Managers Under a Microscope Once Again
As of July 1, a Florida bill increases oversight of pharmacy benefit managers and offers some protection for pharmacies. However, the legislation has limited effects on patients and providers, highlighting the need for additional reform.